Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 18/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 14/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 14/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 14/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 13/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 13/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 13/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 13/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5991498 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL30985375 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5991495 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5994501 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5991499 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5991491 | 1.00 | HDAC1 (0.60) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL30985379 | 0.95 | HDAC1 (0.59) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5993229 | 0.95 | HDAC1 (0.59) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5993238 | 0.95 | HDAC1 (0.59) | HDAC1HDAC2HDAC11HDAC8HDAC6 | |
| SCHEMBL5741253 | 0.91 | MEN1 (0.50) | HDAC1HDAC2HDAC11HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153687-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | TAIWANJ PHARMACEUTICALS CO., LTD. (TW) | 2022-05-19 | — | — | US | disclosed |
| EP-3946299-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | Taiwanj Pharmaceuticals Co., Ltd. (TW) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020205455-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | TAIWANJ PHARMACEUTICALS, CO., LTD. (TW) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020205455-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | TAIWANJ PHARMACEUTICALS, CO., LTD. (TW) | 2020-10-08 | — | — | WO | disclosed |
| US-20060063760-A1 | Hydroxamic acids useful in the treatment of hyper-proliferative disorders | BAYER PHARMACEUTICALS CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063760-A1 | Hydroxamic acids useful in the treatment of hyper-proliferative disorders | MKI67, PCNA, CCNA1 | HDAC1 559/4885HDAC2 1357/4885HDAC11 338/4885 |
| US-20220153687-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | AADAC, ENPP2, ATXN10 | HDAC1 21/4885HDAC2 36/4885HDAC11 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.